What is Exelixis's gross profit?

Exelixis (EXEL) reported gross profit of $590.86M in Q1 2026.

How has Exelixis's gross profit changed year-over-year?

Exelixis's gross profit increased by 10.2% year-over-year, from $536.28M to $590.86M.

What is the long-term trend for Exelixis's gross profit?

Over 4 years (2021 to 2025), Exelixis's gross profit has grown at a 12.8% compound annual growth rate (CAGR), from $1.38B to $2.24B.

Exelixis EXEL Gross Profit

Gross Profit at other companies

Eli LillyLLY

$16.22B+54.4%

PfizerPFE

$10.9B+0.3%

IncyteINCY

——

Ionis PharmaceuticalsIONS

——

BridgeBio PharmaBBIO

——

Neurocrine BiosciencesNBIX

——

Other financials

Income statement

See full

Revenue$610.8M+10.0%

Operating income$251.3M+34.5%

Net income$210.5M+31.9%

EPS (diluted)$0.79+43.6%

Balance sheet

See full

Cash & equivalents$226.2M+23.1%

Total debt$169.5M-9.4%

Total equity$1.9B-9.2%

Total assets$2.6B-8.6%

Cash flow

See full

Operating cash flow$251.8M+19.1%

CapEx$1.5M-48.9%

Free cash flow$250.3M+20.1%

Valuation

See full

Market cap$13.05B+10.1%

Enterprise value$12.99B+9.5%

P/E15.7×-2.8×

P/S5.5×+0.3×

Profitability

See full

Gross margin96.4%-0.3pp

Operating margin39.4%+6.3pp

Net margin35.1%+7.1pp

FCF margin38.6%+2.9pp

Returns & leverage

See full

Return on equity41%+10.8pp

Debt / equity0.1×0.0×

Current ratio3.3×-0.2×

Where this comes from

Calculated from Exelixis’s reported figures.

$610.8Mtotal revenue−$20.0Mtotal cost of revenue=$590.86M

The official record: Exelixis’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Exelixis's gross profit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Exelixis's gross profit?: Exelixis (EXEL) reported gross profit of $590.86M in Q1 2026.
How has Exelixis's gross profit changed year-over-year?: Exelixis's gross profit increased by 10.2% year-over-year, from $536.28M to $590.86M.
What is the long-term trend for Exelixis's gross profit?: Over 4 years (2021 to 2025), Exelixis's gross profit has grown at a 12.8% compound annual growth rate (CAGR), from $1.38B to $2.24B.